(ICAD) Icade - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0000035081
ICAD: Offices, Buildings, Housing, Properties, Developments, Investments
Icade SA (PA:ICAD) is a prominent French real estate company with dual expertise in commercial property investment and development. As of December 31, 2023, their investment portfolio stands at €6.8 billion on a fully consolidated basis, while their development activities generated €1.3 billion in economic revenue for the year. This dual approach positions them as a key player in Frances real estate market, catering to diverse needs across the country.
The companys strategic direction is underpinned by long-term partnerships, enabling them to adapt to evolving industry trends effectively. A core aspect of their strategy is sustainability, with climate action and biodiversity preservation integral to their business model. This commitment is evident in their efforts to create sustainable urban environments, aligning with global ESG (Environmental, Social, and Governance) trends.
As a SIIC (Société dInvestissement Immobilier Côtée), Icade is listed on Euronext Paris, offering transparency and liquidity to investors. Their major shareholder, Caisse des Dépôts, underscores their strong institutional backing. This structure provides stability and strategic alignment, crucial for long-term growth and investor confidence.
Financially, Icade presents an intriguing profile with a market capitalization of €1.74 billion. The price-to-book (P/B) ratio of 0.40 suggests potential undervaluation relative to book value, while the forward P/E of 7.36 indicates reasonable valuation expectations. These metrics, alongside a P/S ratio of 1.14, provide a comprehensive view of their market positioning and investment appeal.
For investors and fund managers, Icades diversified portfolio spanning offices, healthcare facilities, and urban renewal projects offers stability and growth potential. Their focus on sustainability not only aligns with global trends but also enhances long-term asset value and tenant appeal. This strategic blend of financial prudence and sustainability makes Icade a compelling consideration for those seeking exposure to the French real estate sector.
Additional Sources for ICAD Stock
ICAD Stock Overview
Market Cap in USD | 1,679m |
Sector | Real Estate |
Industry | REIT - Diversified |
GiC Sub-Industry | Diversified REITs |
IPO / Inception |
ICAD Stock Ratings
Growth 5y | -52.0% |
Fundamental | -16.9% |
Dividend | 83.2% |
Rel. Strength | -7.1 |
Analysts | - |
Fair Price Momentum | 24.11 EUR |
Fair Price DCF | 31.84 EUR |
ICAD Dividends
Dividend Yield 12m | 32.62% |
Yield on Cost 5y | 16.65% |
Annual Growth 5y | 3.83% |
Payout Consistency | 92.8% |
ICAD Growth Ratios
Growth Correlation 3m | 30.8% |
Growth Correlation 12m | 3.7% |
Growth Correlation 5y | -83% |
CAGR 5y | -12.24% |
CAGR/Max DD 5y | -0.20 |
Sharpe Ratio 12m | -0.14 |
Alpha | -5.69 |
Beta | 1.218 |
Volatility | 25.65% |
Current Volume | 122.4k |
Average Volume 20d | 162.8k |
As of April 03, 2025, the stock is trading at EUR 20.76 with a total of 122,350 shares traded.
Over the past week, the price has changed by +1.17%, over one month by +4.22%, over three months by +0.66% and over the past year by +5.31%.
Neither. Based on ValueRay Fundamental Analyses, Icade is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -16.93 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ICAD as of April 2025 is 24.11. This means that ICAD is currently undervalued and has a potential upside of +16.14% (Margin of Safety).
Icade has no consensus analysts rating.
According to ValueRays Forecast Model, ICAD Icade will be worth about 26 in April 2026. The stock is currently trading at 20.76. This means that the stock has a potential upside of +25.43%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 27.9 | 34.4% |
Analysts Target Price | - | - |
ValueRay Target Price | 26 | 25.4% |